Arcadis (ARCAY)
(Delayed Data from OTC)
$62.90 USD
+1.60 (2.61%)
Updated Apr 4, 2024 09:30 AM ET
4-Sell of 5 4
C Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for Arcadis NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 5,415 | 4,245 | 3,997 | 3,773 | 3,890 |
Cost Of Goods | 1,346 | 1,064 | 963 | 925 | 1,004 |
Gross Profit | 4,069 | 3,180 | 3,034 | 2,848 | 2,886 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,761 | 2,951 | 2,767 | 2,753 | 2,689 |
Income After Depreciation & Amortization | 307 | 229 | 267 | 95 | 197 |
Non-Operating Income | 20 | 6 | 19 | 36 | -82 |
Interest Expense | 86 | 29 | 26 | 44 | 53 |
Pretax Income | 241 | 206 | 260 | 87 | 61 |
Income Taxes | 68 | 64 | 61 | 63 | 45 |
Minority Interest | 0 | -1 | 0 | -1 | 3 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 173 | 142 | 199 | 24 | 17 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 173 | 143 | 199 | 25 | 14 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 495 | 357 | 400 | 263 | 346 |
Depreciation & Amortization (Cash Flow) | 188 | 127 | 133 | 167 | 149 |
Income After Depreciation & Amortization | 307 | 229 | 267 | 95 | 197 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 89.80 | 89.16 | 89.78 | 89.60 | 87.87 |
Diluted EPS Before Non-Recurring Items | 2.72 | 2.38 | 2.32 | 1.69 | 1.60 |
Diluted Net EPS (GAAP) | 1.93 | 1.60 | 2.21 | 0.27 | 0.16 |
Fiscal Year end for Arcadis NV falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |